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Abstract  Deep  brain  electrical  stimulation  of  the  ventro-medial  globus  pallidus  in  Parkinson’s
disease (PD)  is  an  alternative  in  the  treatment  of  rigidity  in  advanced  cases  which  do  not
response to  conventional  pharmacological  treatment.
Objective:  To  measure  the  clinical  changes  and  collateral  effects  of  bilateral  electric  stimu-
lation of  the  ventro-medial  globus  pallidus,  in  a  sample  of  patients  suffering  from  Parkinson’s
disease with  predominance  of  rigidity.
Methodology:  An  auto-control  study  of  direct  assignation  was  carried  out,  open  to  evaluate  the
changes according  to  the  Uniﬁed  Parkinson  Disease  Rating  Scale  III  (UPDRS  III)  in  a  basal  period,
within 6  and  12  months  of  follow  up  same  as  the  collateral  effect  and  the  medicament  doses.
Results: 12  patients  were  included  (5  women)  with  ages  of  62.4  ±  12.7  years  (media  ±  DE),
history of  PD  was14.2  ±  5.3  years,  with  Hoehn  and  Yahr  stages  within  II  and  IV.  UPDRS  III  score
in OFF-  medication  of  73  ±  11.3.  Beyond  6  months  of  follow  up,  a  signiﬁcant  statistical  change
towards tremor,  rigidity,  bradykinesia,  posture  and  gait,  can  be  appreciated  (p  <  0.05).  The  best
effect can  be  observed  in  the  qualiﬁcation  of  UPDRS  III  after  implantation  (35  to  38  delta  points
of the  scale)  and  for  stimulation  particularly  for  bradykinesia  (delta  of  11  points).  There  were  no
signiﬁcant changes  in  levodopa  doses.  The  collateral  effects  such  as  phosphenes,  contralateral
paresthesias,  deviation  of  labial  commissure  and  dysarthria,  were  avoided  with  the  adjustment
of stimulation  parameters  during  the  surgery.
Conclusion:  This  study  suggest  that  bilateral  implantation  of  the  ventro-medial  globus  pallidus
is an  efﬁcient  and  safe  method  in  patients  PD  with  rigidity  implanted  in  the  Hospital  Central
Militar.
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Experiencia  clínica  en  el  Hospital  Central  Militar  con  la  estimulación  cerebral
profunda  del  globo  pálido  interno  ventro-medial  en  pacientes  con  enfermedad  de
Parkinson
Resumen  La  estimulación  eléctrica  cerebral  profunda  del  globo  pálido  interno  en  la  enfer-
medad de  Parkinson  es  una  alternativa  para  resolver  la  rigidez  de  los  casos  avanzados  que  no
responden  al  tratamiento  farmacológico  convencional.
Objetivo:  Medir  los  cambios  clínicos  y  los  efectos  colaterales  de  la  estimulación  eléctrica  bilat-
eral del  globo  pálido  en  una  muestra  de  pacientes  con  enfermedad  de  Parkinson  con  predominio
de rigidez.
Metodología:  Se  aplicó  un  estudio  autocontrolado  de  asignación  directa,  abierto  para  evaluar
los cambios  en  la  Uniﬁed  Parkinson  Disease  Rating  Scale  III  en  el  período  basal  y  entre  los  6  y
12 meses  de  seguimiento  al  igual  que  los  efectos  colaterales  y  en  la  dosis  de  medicamento.
Resultados:  Se  incluyeron  12  pacientes  (5  mujeres)  con  edad  de  62.4  ±  12.7  an˜os  (media  ±  DE),
tiempo de  evolución  de  14.2  ±  5.3  an˜os,  con  estadio  de  Höhen  y  Yahr  entre  II  y  IV.  Con  una
caliﬁcación  en  OFF-  medicación  83.6  ±  11.08  y  en  ON  --  medicación  de  73  ±  11.3.  A  más  de
6 meses  de  seguimiento  se  observó  un  cambio  estadísticamente  signiﬁcativo  hacia  la  mejoría
del temblor,  la  rigidez,  la  bradicinesia,  la  postura  y  la  marcha  (p  <  0.05).  El  mejor  efecto  se
observó en  la  caliﬁcación  del  UPDRS  III  posterior  a  la  implantación  (delta  de  35  a  38  puntos  de
la escala)  y  para  estimulación  particularmente  para  la  bradicinesia  (delta  de  11  puntos).  No
hubo un  cambio  signiﬁcativo  en  la  dosis  de  levodopa.  Los  efectos  colaterales  como  fosfenos,
parestesias  contralaterales,  desviación  de  la  comisura  labial  y  disartria  fueron  evitados  con  el
ajuste de  parámetros  de  estimulación  durante  la  cirugía.
Conclusión:  Este  estudio  sugiere  que  la  implantación  bilateral  del  globo  pálido  interno  es  un
método eﬁciente  y  seguro  en  pacientes  con  EP  rígidos  implantados  en  el  Hospital  Central  Militar.
© 2014  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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implantation  were  corroborated  through  an  axial  computedIntroduction
Parkinson’s  disease  (PD)  presents  a  different  prevalence
depending  of  the  ethnical  group  or  the  geographic  region
studied.  Indeed,  PD  is  considered  that  it  affects  between
1  and  2%  of  the  population  older  than  60  years 1,2.  Unfortu-
nately,  the  medical  treatment  presents  important  secondary
effect  in  more  than  50%  of  the  cases  after  5  years  of
treatment,  due  to  the  motor  ﬂuctuations  occasioned  by
pharmacokinetic  and  pharmacodynamics  of  chronic  use
medicaments,  collateral  effects  of  the  same  (dyskinesia)
and  by  the  answer  absence  of  some  signs  such  as  bradykine-
sia,  posture  disorders  and  gait 3,4.
Bilateral  electric  stimulation  of  the  ventro-medial  globus
pallidus  has  been  an  alternative  treatment  since  the  original
works  of  Siegfried  and  Lipptiz  in  1994 5 and  is  considered  a
useful  option  in  the  treatment  of  patients  with  Parkinson’s
disease,  mainly  with  predominant  rigidity  and  bradykinesia.
5--11.
Some  alternatives  like  stimulation  of  the  subthalamic
nucleus  or  pallidotomy  are  widespread  and  are  currently
used.  However,  These  procedures  show  collateral  effects
which  can  be  considered  daunting 11--15.  The  ventro-medial
globus  pallidus  can  be  an  area  of  brain  stimulation  with
a  good  clinical  effect  over  the  illness  and  with  a  shorter
amount  of  complications.The  objective  of  this  work  was  to  quantify  the  clinical
change  in  a  sample  of  patients  with  PD  from  the  Hospital
Central  Militar,  with  predominance  of  rigidity,  subdued  to
t
i
wilateral  electric  stimulation  of  the  ventro-medial  globus
allidus.
atients and methods
he  target  population  was  deﬁned  as:  those  patients  with
iagnosed  PD,  that  were  beneﬁciaries  of  the  Hospital  Central
ilitar,  with  deﬁnitive  diagnosis  of  this  condition  accord-
ng  to  the  United  Kingdom  Parkinson’s  Disease  Society  Brain
ank  Clinical  Diagnostic  Criteria 16,  with  a  minimal  age  of  50
ears,  with  a  minimal  evolution  time  of  5  years,  in  Hoehn  and
ahr  stage  within  II  and  IV 17, with  predominance  of  rigidity,
osture  and  gait  alterations,  without  any  important  cogni-
ive  impairment,  with  partial  response  to  levodopa,  without
ny  important  surgical  risk  according  to  the  qualiﬁcation  of
he  American  Society  of  Anaesthesiology.
The  clinimetric  evaluations  were  effectuated  by  a  neurol-
gist  specialized  in  movement  disorders.  Two  neurosurgeons
valuated  every  case  and  decided  the  pertinence  of  the  sur-
ical  target.  The  follow  up  was  effectuated  within  6  and  12
onths  through  the  design  of  a  self-controlled  study,  open
nd  of  direct  assignation.  Surgical  procedure  was  performed
ith  Zamorano  Dujovny  stereotactic  frame  and  IPS  system
or  implantation  (Inomed,  Frieburg  Germany).  The  sites  ofomography  or  by  postoperative  magnetic  resonance.  A  reg-
ster  of  the  stimulation  parameters  and  the  collateral  effects
as  performed.  The  design  included  descriptive  statistic  for
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Table  1  This  table  shows  demographic  data  of  12  patients  enrolled  in  this  study.  Initial  scores  of  every  important  sign  were
recorded in  OFF  and  ON  medical  condition.  Also  It  is  showing  is  UPDRS  III  score  were  recorded.  Symmetry  and  kurtosis  are  showed
in order  to  review  normal  distribution  of  sample.
Variable  Minimum  Maximum  Media  SD  Symmetry  Kurtosis
Age  44  82  62.4  12.7  -0.032  -1.440
EP years  6  25  14.2  5.3  0.610  0.165
Tremor OFF  1  12  7.6  3.8  -0.537  -0.821
Rigidity OFF  4  12  8.8  2.4  -0.749  -0.108
Bradi OFF  4  31  14.2  7.8  0.909  0.609
Posture OFF  0  4  2.2  1.1  -0.385  -0.055
Gait OFF 1  4  2.4  1.2  -0.174  -1.523
Hoehn/Yahr 2  4  3.1  1.1  -0.792  -1.081
UPDRS OFF 61  111  83.6  11.8  0.540  2.755
UPDRS ON  59  98  73  11.3  0.717  0.861
Ldopa mg/d  0  2000  789.1  792.6  0.386  -1.576
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Figure  1  Box  plot  graphic  shows  statistical  results  through
Wilcoxon  test.  There  is  signiﬁcant  delta  (p  =  0.005)  between  the
period without  levodopa  previous  and  after  electrical  stimula-
tion (OFF-OFF  versus  OFF-ON).  Similarly,  during  levodopa  period
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DSD = standar deviation.
emographic  variables  and  the  range  proofs  of  Wilcoxon  for
he  outcome  variables.
esults
emographic  data  is  showing  in  Table  1.  Twelve  patients
ith  PD  were  included  (5  women  and  7  men)  with  ages  of
2.4  ±  12.7  (Media  ±  standard  deviation),  history  of  PD  of
4.2  ±  5.3  years,  with  Hoehn  and  Yahr  stage  within  II  and  IV.
hey  showed  predominance  of  rigidity.  UPDRS  III  score  OFF
-  medication  was  83.6  ±  11.08  and  in  ON  -  medication  of
3  ±  11.3.  Patients  reported  doses  of  levodopa  of  789  ±  792
g/day.  They  were  underwent  to  a  bilateral  stereotac-
ic  implantation  of  electrodes  in  the  ventro-medial  globus
allidus  through  Zamorano  Dujovny  stereotactic  frame,  CT
can  slides  were  fused  with  MRI  slices  thought  out  IPS
ystem  and  indirect  and  direct  calculation  of  coordinates
llowed  lead  location.  Bilateral  implantation  was  made  in
wareness  condition  using  local  anaesthesia.  Entry  points
ere  performed  just  over  coronal  suture  and  35  mm  lat-
ral  from  midline.  Micro-recording  system  was  not  used.
MI  or  CT  scan  was  performed  immediately  after  implan-
ation  in  order  to  conﬁrm  right  location  and  absence  of
leeding.  Internalization  of  Activa  system  by  Medtronic  was
ade  in  the  same  day.  Results  of  mean  of  coordinates
±SD)  in  mm  were  for  right  side  (x  =  20.5  ±  1.5,  y  =  1.9  ±  1.7,
 =  -3.5  ±  0.5)  and  for  left  side  (x  =  19.7  ±  1.1,  y  =  2.6  ±  1.8,
 =  -3.3  ±  0.6).(Figs.  1  and  2)
The  ranges  in  the  stimulation  parameters  applied  for
mplitude,  have  been  of  1.3  to  2.5  volts,  for  the  width
f  60  to  120  microseconds,  for  a  frequency  of  120  to  145
ertz,  for  impedance  of  992  to  3450  ohms,  with  stimula-
ion  mono  or  bipolar  depending  on  the  best  reaction  (Lead
389  and  Activa  RC  by  Medtronic  Minneapolis  MN).  A  evalu-
tion  with  the  UPDRS  III  scale  was  made  in  order  to  measure
heir  clinic  performance,  and  was  followed  up  for  6  to  12
onths.(Table  2)
Beyond  6  months  of  follow  up,  a  signiﬁcant  statistical
hange  could  be  appreciated  in  the  improvement  of  the
remor,  the  rigidity,  bradykinesia,  posture  and  gait  (p  <  0.05)
ccording  to  a  paired  t-Student  test.  The  best  effect  was
I
g
Phere was  signiﬁcant  differences  (p  =  0.013)  (ON-OFF  contra  ON-
N).  By  other  side,  there  was  not  effect  by  levodopa  both  pre
r postoperative  period  (OFF-OFF)  (ON-OFF)  (p  =  0.213).
bserved  in  the  UPDRS  III  score  after  implantation  (max-
mum  delta  of  35  to  38)  and  for  stimulation  particularly
or  bradykinesia  (delta  11  points)  according  to  a  range  of
ilcoxon  test.  There  were  no  signiﬁcant  changes  in  the
oses  of  levodopa.  No  permanent  secondary  effects  were
ound.  Collateral  effects  over  sight  were  present  in  a  case
s  well  as  the  stimulation  of  the  internal  capsule  (contralat-
ral  paraesthesia  of  the  face  or  hemibody,  and  deviation
f  the  labial  commissure)  or  speech  was  avoided  with  the
djustment  of  stimulation  parameters  during  the  surgery.
iscussionn  this  study  the  electric  stimulation  of  the  ventro-medial
lobus  pallidus  improved  the  performance  of  patients  with
D  in  advanced  phase,  considering  the  diminishment  in  the
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Table  2  In  this  table  is  showing  minimal,  maximal  differences  and  media  of  delta  changes  of  cardinal  signs  in  the  sample  of
patients. Signiﬁcant  changes  were  evaluated  through  t-paired  test.  The  only  variable  without  statistical  changes  was  levodopa
doses.
Basal  versus  postoperative  period  Minimum  Maximum  Media  of  delta  Standard  Error  P  value
Tremor  OFF  5.6  4.38  1.38  8.73  0.003
Rigidity OFF  3.7  4.16  1.32  6.68  0.02
Bradikinesya  OFF  11.4  9.58  3.03  18.25  0.004
Posture OFF  1.5  1.58  0.5  2.63  0.015
Gait OFF  1.5  1.27  0.4  2.41  0.005
Höehn &  Yahr  0.9  1.22  0.38  1.77  0.045
UPDRS OFF 25.11  38.52  7.94  56.46  0.001
UPDRS ON 29.46  35.00  9.32  56.08  0.005
Levodopa mg/day 265.07  948.09  
Figure  2  Axial  MRI  view  of  bilateral  implantation  of  DBS  into
ventromedial  globus  pallidus  is  showed.  Mean  of  coordinates
(±SD) in  mm  were  for  right  side  (x  =  20.5  ±  1.5,  y  =  1.9  ±  1.7,
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Referencesz =  -3.5  ±  0.5)  for  left  side  (x  =  19.7  ±  1.1,  y  =  2.6  ±  1.8,
z =  -3.3  ±  0.6).  Arrows  show  location  of  leads  in  Gpi.
qualiﬁcation  of  the  UPDRS  III  scale.  This  change  translates
to  the  diminishment  in  the  intensity  of  cardinal  signs  of  the
disease,  in  particular  the  qualiﬁcation  of  bradykinesia  with
an  average  reduction  of  3  points.  This  data  is  similar  to  the
reported  for  electric  stimulation  of  subthalamic  nucleus  and
of  the  ventro-medial  globus  pallidus  by  other  groups 11,18.
Up  to  this  moment,  the  target  selection  to  obtain  the  best
effect  out  of  the  stimulation  depends  on  the  probability
to  improve  the  more  incapacitating  signs,  the  frequency
with  which  these  collateral  effects  can  complicate  the
clinical  picture  and  especially  by  the  ability  to  implant
the  electrodes  with  precision.  In  consequence,  the  electric
stimulation  of  the  ventro-medial  globus  pallidus  remains358.34  1141.91  0.487
s  one  of  the  major  alternatives  to  improve  rigid-akinetic
atients 10,18. As  far  as  we  know,  the  action  mechanisms  of
lectric  stimulation  of  the  ventro-medial  globus  pallidus  and
f  the  subthalamic  nucleus  are  similar  whether  in  function
f  the  spontaneous  somatic  activity  inhibition  of  neurones
lose  to  the  electrode,  to  the  depolarizing  effect  of  these
ucleus  exit  paths  or  of  the  important  interconnectivity
nd  interaction  that  exists  between  these  two  anatomic
tructures 18.  It  is  probable  that  electric  stimulation  of  the
entro-medial  globus  pallidus  could  produce  a propagation
ffect  within  the  neuronal  net  and  thus  facilitate  the  motor
nswer  of  a  bradykinetic  patient,  in  a  similar  way  to  the
ubthalamic  nucleus.
There  were  various  limitations  in  this  study,  such  as  the
pen  design  and  the  direct  manoeuvre  assignation,  also  the
racking  and  the  number  of  patients  could  be  relative  limita-
ions.  However,  this  studyis  an  approximation  as  a  pragmatic
tudy  within  a  recently  installed  stereotactic  neurosurgery
nit  to  perform  electric  brain  stimulation  into  adequate
linimetric  assays.
onclusions
his  study  suggests  that  bilateral  implantation  of  the  ventro-
edial  globus  pallidus  is  an  efﬁcient  and  safe  method  in
atients  with  severe  PD  implanted  in  the  Hospital  Central
ilitar.
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